Hesperetin promotes longevity and delays aging via activation of Cisd2 in naturally aged mice.
Artificial-Intelligence-Assisted Discovery of Genetic Factors for Precision Medicine of Antiplatelet Therapy in Diabetic Peripheral Artery Disease.
Rejuvenating the aging heart by enhancing the expression of the Cisd2 prolongevity gene.
Artificial intelligence-assisted identification of genetic factors predisposing high-risk individuals to asymptomatic heart failure.
CISD2 maintains cellular homeostasis. B
Progressing left-side sciatica revealing a common iliac artery mycotic aneurysm in an elderly patient: A CARE-compliant case report.
Mitochondria and calcium homeostasis: Cisd2 as a big player in cardiac ageing.
Radial artery harvesting in coronary artery bypass grafting surgery - endoscopic or open method? A meta-analysis.
Using a incentive spirometer device reduces pulmonary complications in patients with traumatic rib fractures: A randomized controlled trial.
Cisd2 is essential to delaying cardiac aging and to maintaining heart functions.
Initiation of antiplatelet medication after surgical thrombectomy jeopardized arteriovenous graft longevity.
Inhibition of miR-302 suppresses hypoxia-reoxygenation-induced H9c2 cardiomyocytes death by regulating Mcl-1 expression.
Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor.
Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
1.胸腔鏡手術，第16章 微創冠狀動脈繞道術，合記圖書出版社，p141-6
2.Yeh CH, Lin PJ, Chu JJ. Collagen as a drug carrier for deep sternal wound infection after open heart surgery. Chang Gung Med J 2001;24(7):451-4 (Jul)
3.Yeh CH, Lin PJ, Chu JJ, Tsai KT, Chang YS. Safety and cost-effectiveness of minimal access versus conventional coronary artery bypass grafting in emergent patients. Chang Gung Med J 2002;25(2):89-96. (Feb)
4.Thesis : The possible mechanism of cardioplegia-induced cardiomyocytic apoptosis after global cardiac ischemia/reperfusion injury Jan 2004
5.Yeh CH, Chang CH, Lin PJ*, Tsai FC, Yang MW, Tan PP. Totally minimal invasive cardiac surgery for coronary artery disease. Eur J Cardio-Thorac Surg 1998;14(Suppl 1): S43-7 (Oct)
6.Yeh CH, Chen HM*, Jan YY, Hwang TL, Jeng LB, Chen MF. Clinical analysis of inflammatory masses of the pancreatic head region. Hepato-Gastroenterology 1998;45(24): 2392-8 (Nov-Dec)
7.Wu YC, Lu MS,Yeh CH, Liu YH, Hsieh MJ, Lu HI, Liu HP*. Justifying video-assisted thoracic surgery for spontaneous hemopneumothorax. Chest 2002;122(5):1844-7(Nov)
8.Yeh CH*, Lin PJ. Inhibition of NFKB activation with curcumin attenuates cardiomyocytic apoptosis following cardiac global ischemia and reperfusion. Circulation 2002; 106(19 suppl II):II-344
9.Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ*. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest 2003;123(5):1647-54. (May)
10.Yeh CH, Chen MC, Wu YC, Wang YC, Chu JJ, Lin PJ﹡. Risk factors for descending aortic aneurysm formation in long-term follow-up of patients with type A aortic dissection. Chest 2003;124(3): 989-95. (Sep)
11.Wu YC, Chu Y, Liu YH, Yeh CH, Chen TP, Liu HP﹡. Thoracoscopic ipsilateral approach to contralateral bullous lesion in patients with bilateral spontaneous pneumothorax. Ann Thorac Surg 2003;76(5):1665-7. (Nov)
12.Lu MS, Liu HP, Yeh CH, Wu YC﹡, Liu YH, Hsieh MJ, Chen TP. The role of surgery in hemoptysis caused by thoracic actinomycosis; a forgotten disease. Eur J Cardiothoracic Surg 2003; 24(5):694-8. (Nov)
13.Yeh CH, Pang SJH, Wu YC, Wang YC, Chu JJ, Lin PJ﹡. Differential-display polymerase chain reaction identifies NADH: ubiquinone oxidoreductase as an ischemia/reperfusion-regulation gene in cardiomyocytes. Chest 2004;125(1):228-35. (Jan)
14.Chu PH*, Jung SM, Yeh CH, Yeh TS, Wang CL. Mucin gene expression in cardiac myxoma. Int J Clin Pract 2004;58(3): 306–9. (Mar)
15.Yeh CH, Lin YM, Wu YC, Wang YC, Lin PJ*. Nitric oxide attenuates cardiomyocytic apoptosis via diminish mitochondrial complex I upregulation from cardiac ischemia/reperfusion injury under cardiopulmonary bypass. J Thorac Cardiovasc Surg 2004;128(2):180-188. (Aug)
16.Yeh CH, Wang YC, Wu YC, Lin YM, Lin PJ. Ischemic preconditioning or heat-shock pre-treatment ameliorates neuronal apoptosis following hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2004;128(2):203-10. (Aug)
17.Yeh YH, Chu PH, Yeh CH, Jan Wu YJ, Lee MH, Jung SM, Kuo CT. Haemophilus influenzae pericarditis with tamponade as the initial presentation of systemic lupus erythematosus. Int J Clin Pract 2004;58(11);1045-7. (Nov)
18.Yeh CH*, Lin YM, Wu YC, Lin PJ. Inhibition of NF-κB activation can attenuate ischemia/reperfusion induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Phar 2005;45(4):301-309. (April)
19.Yeh CH*, Chen TP, Wu YC, Lin YM, Lin PJ. Inhibition of NFκB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res 2005;125(1):109-116.(May)
20.Chu PH*, Jung SM, Lin HC, Yeh CH, Wu HH, Shiu TF, Huang SL, Tseng NM, Chu JJ, Lin PJ, Lai CH. Caspase-3-dependent apoptosis in cardiac myxoma: not associated with human papillomavirus or Epstein–Barr virus. Modern Pathology 2005;18 : 822–827.(May)
21.Yeh CH*, Chen TP, Lee CH, Lin YM, Lin PJ. Exogenous nitric oxide prevents the cardiomyocytic inflammatory response after cardioplegia-induced cardiac ischemia/reperfusion under cardiopulmonary bypass via inhibition of Nf-κB. Circulation 2005; 112(17 Suppl II): II-334
22. Wang CH*, Verma S, Kuo LT, Hsu CM, Lan YJ, Yeh CH, Yang NI, Wang SY, Wu MY, Cheng CW, Hung MJ, Cherng WJ. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Circulation 2005; 112(17 Suppl II): II-46
23.Yeh CH*, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ. Inhibition of Poly (ADP-Ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass. Shock 2006; 25(2): 168-175.(Feb) (SCI; IF=2.848; Surgery 30/198)
24.Jenq CC*, Chen YC, Huang JY, Wu CH, Yeh CN, Yeh CH, Tseng JH, Hsu PY, Tian YC, Fang JT, Yang CW. Type B aortic dissection with early presentation mimicking acute pyelonephritis. J Nephrol 2006; 19(3):341-5 (May-Jun). (SCI; IF=2.015; UROLOGY & NEPHROLOGY 39/69)
25.Yeh CH*, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor-alpha but not gamma activators. Shock 2006; 26(3):262-270 (Sep) (SCI; IF=2.848; Surgery 30/198)
26.Yeh CH*, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ. Cardioplegia-induced cardiac arrest under cardiopulmonary bypass decreased nitric oxide production which induced cardiomyocytic apoptosis via NF-κB activation. Shock 2007;27(4):422-428. (Apr) (SCI; IF=2.848; Surgery 30/198)
27.Chen TP, Yeh CH, Wu YC, Liu HP*. Combined pedicled antropyloroplasty and gastric pull-up reconstruction for corrosive esophagogastric stricture. J Thorac Cardiovasc Surg 2007;133(6):1669-71. (Jun) (SCI; IF=3.6087; Surgery 13/198)
28.Fang BR*, Ng YT, Yeh CH. Intravenous leimyomatosis with extension to the heart: Echocardiographic features. Angiology 2007; 58(3):376-9. (June/July) (SCI; IF=1.122; PERIPHERAL VASCULAR DISEASE 56/68)
29.Wang CH*, Cherng WJ, Yang NI, Kuo LT, Hsu CM, Yeh HI, Lan YJ, Yeh CH, Stanford WL. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscl Thromb Vas. 2008(1); 28: 54-60. (Jan) (SCI; IF=7.215; PERIPHERAL VASCULAR DISEASE 3/68)
30.Wang CH*, Cherng WJ, Yang NI, Hsu CM, Yeh CH, Lan YJ, Wang JS, Verma S. Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Am J Physiol Regul Integr Comp Physiol 2008; 294: R811 - R818.(Mar) (SCI; IF=3.284; PHYSIOLOGY 24/78)
31.Chu PH, Jung SM, Yeh CH, Wu HH, Shiu TF, She HC, Tseng NM. Expression of caspase-3-dependent apoptosis in mural thrombi leukocytes. APMIS 2008;116: 995-9. (SCI; IF=2.068; PATHOLOGY 38/76)
32.Yeh CH*, Chen TP, Wang YC, Lin YM, Lin PJ. HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-κB and AP-1 translocation following cardiac global ischemia and reperfusion. J Surg Res 2009; 155: 147-156. (SCI; IF=2.239; Surgery 51/198)
33.Liu KS, Chu JJ, Yeh CH, Chen Y*. Left subclavian artery aneurysm in association with coarctation of aorta, aberrant right subclavian artery, and common origin for bilateral carotid arteries. Eur J Cardiothorac Surg. 2010;37(4):950-1. (SCI; IF=2.647; Surgery 33/198)
35.Yeh CH*, Chen TP, Wang YC, Lin YM, Fang SW. AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress. Mediat Inflamm 2010; Article ID 130636, 9 pages,. doi:10.1155/2010/130636. (SCI; IF=3.263; IMMUNOLOGY 59/139)
36.Yeh CH*, Chen TP, Wang YC, Lin YM, Fang SW. Cardiomyocytic apoptosis limited by bradykinin via restoration of nitric oxide after cardioplegic arrest. J Surg Res 2010; 163 (1): e1-e9 (September). (SCI; IF=2.239; Surgery 51/198)
37.Yeh CH*, Chen TP, Wang YC, Lin YM, Fang SW. MicroRNA-27a regulates cardiomyocytic apoptosis during cardioplegia-induced cardiac arrest under cardiopulmonary bypass by targeting interleukin-10-related pathway. Circulation. 2011; 124: A15934
38.Yu HC, Tsai YF*, Chen MC, Yeh CH. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. Int J Stroke 2012;7:112-117. (SCI; IF=2.382; PERIPHERAL VASCULAR DISEASE 33/68)
39.Chao YK*, Liu HP, Hsieh MJ, Wu YC, Liu YH, Yeh CH, Chang HK, Tseng CK. Impact of the number of lymph nodes sampled on outcome in ypT0N0 esophageal squamous cell carcinoma patients J Surg Oncol 2012;106(4): 436–440. (SCI; IF=2.1; Surgery 56/198)
40.Chao YK*, Liu HP, Hsieh MJ, Wu YC, Liu YH, Yeh CH, Chang HK, Tseng CK. Lymph Node Dissection after Chemoradiation in Esophageal Cancer: A Subgroup Analysis of Patients With and Without Pathological Response. Ann Surg Oncol 2012;19(10):3500-3505. (SCI; IF=4.120; Surgery 9/198)
41.Yeh CH*, Chen TP, Wang YC, Lin YM, Fang SW. MicroRNA-27a regulates cardiomyocytic apoptosis during cardioplegia-induced cardiac arrest by targeting interleukin-10 related pathways. Shock 2012;38(6): 607-614. (SCI; IF=2.848; Surgery 30/198)
42.Wang CH*, Lan YJ, Yeh CH, Ng YT, Chung PV-H, Hsu CM, Kuo LT, Huang RE, Liu MH, Cherng WJ. Timing of gangrene tissue debridement after autologous bone marrow cell implantation in patients with superficial femoral arterial occlusion: Preliminary experiences. J Cardiovasc Surg 2012; 53 (4) : 507-516. (SCI; IF=1.51; Surgery 90/198)
43.Chou CC*, Wu YY, Lee JW, Huang JC, Yeh CH. Mechanical properties of fluorinated DLC and Si interlayer on a Ti biomedical alloy. (SCI/EI; IF=1.890; Materials Science, Coatings & Films, 4/18 Q1) (NSC 100-2221-E019-029, NSC 99-2221-E019-007, CMRPG 290502) http://dx.doi.org/10.1016/j.tsf.2012.06.089. Thin Solid Films 2013; 528:136-142. (SCI; IF=1.890; MATERIALS SCIENCE, COATINGS & FILMS 4/18)
44.Wang YC*, Chang CT, Tsu PS, Yeh CH, Chiu WC. Reduction in advanced glycation end products by ACE inhibitor in diabetic cardiomyopathy model. Asian Biomed 2013; 7 (1): 1-6. (SCI; IF=1.559; Surgery 81/198)
45.Chou CC*, Wu YY, Lee JW, Yeh CH, Huang JC. Characterization and haemocompatibility of fluorinated DLC and Si interlayer on Ti6Al4V. Surf Coat Technol. 2013;231:418-422. doi:10.1016/j.surfcoat.2012.01.020. (SCI; IF=1.867; MATERIALS SCIENCE, COATINGS & FILMS 5/18)
46.Yeh CH*, Chen TP, Wang YC, Lin YM, Fang SW. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest. SHOCK 2013;39(4):343-352. (SCI; IF=2.848; Surgery 30/198)
47.Yeh CH*, Chen TP, Wang YC, Fang SW, Wun TC*. Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor. J Thromb Haemost 2013; 11: 1454-1463. DOI: 10.1111/jth.12314 (SCI; IF=6.081; PERIPHERAL VASCULAR DISEASE 7/68)
Presentation :
1.Clinical analysis of inflammatory masses of pancreatic head region. 55th General Scientific Meeting, Surgical Association, ROC. Veterans General Hospital, Taipei. Mar 14, 1996.(oral presentation)
2.Mitral valve reoperaiton. 26th Annular convention & scientific session, Republic of China Society of Cardiology. Veterans General Hospital, Taipei. May 4, 1996. (oral presentation)
3.Thoracoscopic drainage of paratracheal abscess in patient combined with deep neck infection: case report. 2nd Asian Pacific Workshop & Symposium on Minimally Invasive Thoracic Surgery and 1st International Symposium on Minimally Invasive Cardiac Surgery. Chang Gung Memorial Hospital, Taipei. Dec 11, 1997. (oral presentation)
4.Totally minimally invasive cardiac surgery for coronary artery disease during cardioplegic arrest. 2nd Asian Pacific Workshop & Symposium on Minimally Invasive Thoracic Surgery and 1st International Symposium on Minimally Invasive Cardiac Surgery. Chang Gung Memorial Hospital, Taipei. Dec 11, 1997. (oral presentation)
5.Seven thousand vascular access procedures for hemodialysis in one center- Chang Gung Memorial Hospital at Kaohsiung. 57th General scientific Meeting, Surgical Association, ROC. Taipei International Convention Center, Taipei. Apr 8, 1998. (oral presentation)
6.Totally minimally invasive cardiac surgery for coronary artery disease during cardioplegic arrest. 57th General scientific Meeting, Surgical Association, ROC. Taipei International Convention Center, Taipei. Apr 8, 1998. (oral presentation)
7.Emergent coronary artery bypass graft surgery: Minimal invasive cardiac surgery or standard sternotomy? 2nd Minimally Invasive Thoracic Surgery Interest Group International Symposium. Hong Kong. Nov 20, 1998. (oral presentation)
8.Emergent coronary artery bypass graft surgery: Minimal invasive cardiac surgery or standard sternotomy? 58th General Scientific Meeting, Surgical Association, ROC. Veterans General Hospital, Taipei. Mar 11, 1999. (oral presentation)
9.Rapid-staged aortic surgery for complicated type I sortic dissection. 29th Annular convention & scientific session, Republic of China Society of Cardiology. Taipei International Convention Center, Taipei. May 15, 1999. (oral presentation)
10.Continuous warm blood cardioplegia can ameliorate the occurrence of myocardial apoptosis and coronary impairment in ischemia and reperfusion injury.59th General Scientific Meeting, Surgical Association, ROC. Veterans General Hospital, Taipei. Mar 11, 2000. (oral presentation)
11.Nitric oxide can ameliorated coronary endothelium distruction and myocardial cell apoptosis following cardiac glogal ischemia and reperfusion.59th General Scientific Meeting, Surgical Association, ROC. Veterans General Hospital, Taipei. Mar 11, 2000. (oral presentation)
12.Long term follow-up of type I aortic dissection.59th General Scientific Meeting, Surgical Association, ROC. Veterans General Hospital, Taipei. Mar 11, 2000. (oral presentation)
13.Collagen as a drug carrier for deep sternal wound infection after heart surgery. 30th Annular convention & scientific session, Republic of China Society of Cardiology. Taipei International Convention Center, Taipei. May 20, 2000.(poster)
14.Comparison between off-pump and standard CABG in patients older than seventy. 60th General Scientific Meeting, Surgical Association, ROC. Kaohsiung Medical UniversityHospital, Kaohsiung. Mar 24, 2001(oral presentation)
15.Heat shock protein and ischemia/reperfusion injury: Role of warm blood cardiplegia. 60th General Scientific Meeting, Surgical Association, ROC. Kaohsiung Medical UniversityHospital, Kaohsiung. Mar 24, 2001(oral presentation)
16.The role of nitric oxide in cardiac apoptosis and coronary integrity after global ischemia and reperfusion. 9th annual meeting of the Asian society for cardiovascular surgery, Nagoya, Japan. Mar 28, 2001-------Traveler’s Award (oral presentation)
17.NFkB and apoptosis following global cardiac ishcemia and reperfusion. 10th Annual Meeting of the Asian Society for Cardiovascular Surgery (ASCVS). Jeju Island, Korea. April 17, 2002
18.Up-regulation of a gene homologous to the human mitochondrial NADH: ubiquinone oxidoreductase gene in global cardiac ischemia/reperfusion injury during cardiopulmonary bypass determined by differential display polymerase chain reaction. 33rd World Congress of International College of Surgeons. Taipei, Taiwan. October 29, 2002(oral presentation)
19.Inhibition of NFKB activation with curcumin attenuates cardiomyocytic apoptosis following cardiac global ischemia and reperfusion. 75 th American Heart Association Scientific Session. Chicago, USA. November 17, 2002(poster)
20.Valve surgery in patients with left ventricular dysfunction. 61st General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei. Mar 24, 2003(oral presentation)
21.Nitric oxide can ameliorate global cardiac ischemia/reperfusion injury under cardiopulmonary bypass by up-regulation mitochondrial NADH:Ubiquinone oxidoreductase gene expression. 61st General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei. Mar 24, 2003(oral presentation)
22.The secondary mitral valve involvement in primary aortic valve endocarditis does not influence the in-hospital mortality. 61st General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei. Mar 24, 2003(oral presentation)
23.Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. 62nd General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei. Mar 24, 2004(oral presentation)
24.Cardioplegia-induced ischemia/reperfusion injuries can be attenuated by curcumin via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. 62nd General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei. Mar 24, 2004(oral presentation)
25.Ischemic preconditioning can ameliorate hippocampal CA1 neuronal apoptosis after hypothermic circulatory arrest under cardiopulmonary bypass. 62nd General scientific meeting, surgical association, ROC. National Taiwan University Hospital, Taipei Mar 24, 2004 (oral presentation)
26.Cardioplegia-induced ischemia/reperfusion injuries can be attenuated by nitric oxide via decreasing cardiomyocytic nuclear factor activation. 63rd General scientific meeting, surgical association, ROC. Chang Gung University, Tauoyuan. Mar 27, 2005(oral presentation)
27.Off-pump coronary artery bypass graft surgery in non-dialysis-dependent mild-to-moderate renal dysfunction. 63rd General scientific meeting, surgical association, ROC. Chang Gung University, Tauoyuan. Mar 27, 2005(oral presentation)
28.Inhibition of poly(ADP-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass. 15th World Congress of World Society of Cardio-Thoracic Surgeons. Vilnius, Lithuania. June 20, 2005 (poster)
29.Peroxisome proliferator-activated receptor-alpha activation can attenuate cardiomyocytic apoptosis following global cardiac ischemia and reperfusion. 15th World Congress of World Society of Cardio-Thoracic Surgeons. Vilnius, Lithuania. June 20, 2005 (poster)
30.Major thromboembolic and bleeding complications following mechanical valve replacement. 2005 Annual Meeting and Scientific Congress of Taiwan Association of Thoracic & Cardiovascular Surgery, National Taiwan University Hospital, Taipei. Oct 22, 2005 (Invited speaker)
31.Exogenous nitric oxide prevents the cardiomyocytic inflammatory response after cardioplegia-induced cardiac ischemia/reperfusion under cardiopulmonary bypass via inhibition of NF-κB. 78 th American Heart Association Scientific Session. Dallas, USA. November 13, 2005 (poster)
32.Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor-alpha but not gamma activators. 64th General scientific meeting, surgical association, ROC. Chang Gung University, Tauoyuan. Mar 25, 2006 (oral presentation)
33.Bradykinin limits cardiomyocytic apoptosis via restoration of nitric oxide after cardioplegic arrest. Heart Failure 2006, Helsinki, Finland. Jun 18, 2006 (poster)
34.Regulation of cardiomyocytic apoptosis by ischemia-reperfusion-sensitive transcription factors. 36th Annular convention & scientific session, Republic of China Society of Cardiology. Taipei International Convention Center, Taipei. Sep 16, 2006. (Invited speaker)
35.HO-1 activation can attenuates cardiomyocytic apoptosis via inhibition of NFκB translocation following cardiac global ischemia and reperfusion. 79 th American Heart Association Scientific Session. Chicago, USA. November 12, 2006 (poster)
36.Perioperative And Midterm Outcomes of CABG in Patients Requiring Dialysis: Comparison Between Off- And On-pump CABG. 66th General scientific meeting, surgical association, ROC. Kaohsiung Medical University, Kaohsiung. Mar 29, 2008 (oral presentation)
37.多功能性血液幹細胞分化為平滑肌細胞為動靜脈廔管平滑肌增生的重要病因. 66th General scientific meeting, surgical association, ROC. Kaohsiung Medical University, Kaohsiung. Mar 29, 2008 (oral presentation)
38.Decreased nitric oxide production after cardioplegia-induced cardiac arrest under cardiopulmonary bypass induced cardiomyocytic apoptosis by activation of the unfolded protein response. Heart Failure 2008 Congress. Milan, Italy. June 14-17, 2008
39.AMPK Activation During Cardioplegia-Induced H/R Injury Could Attenuate Cardiomyocytic Apoptosis via Reduction of ER Stress. 45th Annual Meeting of the Scoiety of Thoracic Surgeons San Francisco, USA. January 25, 2009
40.Differiatial anti-apoptotic effects of beta-blocker on post-infarcted myocardium during cardioplegia-indeuced I/R njury Heart Failure 2009 Congress. Nice, France. June2, 2009
41.Microrna-27a Regulates Cardiomyocytic Apoptosis During Cardioplegia-Induced Cardiac Arrest Under Cardiopulmonary Bypass by Targeting Interleukin-10-Related Pathway. 84 th American Heart Association Scientific Session. Orlando, USA. November 14, 2011 (oral presentation)
